Search & Analyze
Popular Searches
Ipca Laboratories Ltd.
Healthcare₹1,764.300.48%
24 Jul, 4:01 PM
CMP₹1,764.30
Mkt Cap₹44.93K Cr
P/E39.38
P/B5.57
ROE15.88%
52W High₹1,941.40
52W Low₹1,252.95
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
39.38
P/B Ratio
5.57
EV/EBITDA
20.90
Price/Sales
4.68
Dividend Yield (%)
0.34
EPS (TTM ₹)
44.98
Book Value (₹)
317.72
ROE (%)
15.88
ROCE (%)
19.41
ROA (%)
9.89
EBITDA Margin (%)
20.26
Net Profit Margin (%)
12.35
Debt/Equity
0.09
Current Ratio
2.76
Interest Coverage
20.88
Asset Turnover
0.80
Working Capital/Sales
2.37
Core EBITDA Growth (%)
18.35
P&L
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 5796.74 | 6204.26 | 7662.43 | 8896.81 | 9599.02 |
| Net Sales | 5796.74 | 6204.26 | 7662.43 | 8896.81 | 9599.02 |
| Total Income | 5918.46 | 6356.03 | 7846.79 | 9048.13 | 9800.71 |
| Total Expenditure | 4539.12 | 5300.99 | 6398.38 | 7226.28 | 7644.55 |
| Operating Profit | 1379.34 | 1055.04 | 1448.41 | 1821.85 | 2156.16 |
| Depreciation | 232.42 | 261.56 | 357.24 | 397.82 | 418.12 |
| Exceptional Items | — | — | -107.75 | -205.05 | -86.43 |
| Profit Before Tax | 1135.72 | 745.29 | 842.67 | 1131.14 | 1572.52 |
| Tax | 224.77 | 253.36 | 313.46 | 343.61 | 381.15 |
| Profit After Tax (PAT) | 910.95 | 491.93 | 529.21 | 787.53 | 1191.37 |
| EPS (₹) | 34.85 | 18.58 | 21.57 | 29.08 | 44.98 |
| Dividend Payout % | 400 | 400 | 400 | 400 | 600 |
Balance Sheet
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 25.37 | 25.37 | 25.37 | 25.37 | 25.37 |
| Reserves | 5439.47 | 5816.65 | 6305.21 | 6920.38 | 8035.3 |
| Shareholders Funds | 5464.84 | 5842.02 | 6332.19 | 6948.45 | 8063.81 |
| Total Debt | 791.24 | 1457.53 | 1387.5 | 1301.7 | 703.94 |
| Total Liabilities | 7621.51 | 8622.86 | 11097.05 | 11743.63 | 12349.65 |
| Total Assets | 7621.51 | 8622.86 | 11097.05 | 11743.63 | 12349.65 |
| Book Value / Share | 215.4056 | 230.2728 | 249.5302 | 273.7781 | 317.7245 |
| Assets | 7621.51 | 8622.86 | 11097.05 | 11743.63 | 12349.65 |
Cash Flows
| Particulars | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) | FY 2025-26 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | 856.07 | 805.81 | 944.65 | 1321.32 | 1141.97 |
| Investing Activities | -855.05 | -725 | -1291.79 | -869.5 | -246.77 |
| Financing Activities | 426.78 | 507.24 | -552.55 | -282.98 | -753.53 |
| Net Cash Flow | 427.8 | 588.05 | -899.69 | 168.84 | 141.67 |
IPCALAB
₹1,764.30
-0.48%